A Phase II Trial of Salirasib in Patients with Lung Adenocarcinomas with KRAS Mutations

2011152 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: Journal of Thoracic Oncology

Volume 6, Issue 8, pp. 1435-1437

Field-Weighted Citation Impact: 8.22